CUTANEOUS SQUAMOUS CELL CARCINOMA (CSCC)
Clinical trials for CUTANEOUS SQUAMOUS CELL CARCINOMA (CSCC) explained in plain language.
Never miss a new study
Get alerted when new CUTANEOUS SQUAMOUS CELL CARCINOMA (CSCC) trials appear
Sign up with your email to follow new studies for CUTANEOUS SQUAMOUS CELL CARCINOMA (CSCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Needle vs knife: new skin cancer treatment could avoid surgery
Disease control Recruiting nowThis study is testing whether injecting an immune-boosting drug directly into an early-stage skin cancer tumor works as well as surgery to remove it. Researchers will compare the drug, cemiplimab, to standard surgical removal in about 369 people with small skin cancers. The main …
Matched conditions: CUTANEOUS SQUAMOUS CELL CARCINOMA (CSCC)
Phase: PHASE3 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Blood test could warn of Cancer's return before scans can see it
Knowledge-focused Recruiting nowThis study is testing a blood test to see if it can find tiny leftover cancer cells after treatment for head and neck cancer. Researchers will follow 250 patients for two years to see if a positive blood test predicts if the cancer will return. The study is observational, meaning…
Matched conditions: CUTANEOUS SQUAMOUS CELL CARCINOMA (CSCC)
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:12 UTC
-
Scientists hunt for clues to make skin cancer treatment more personal
Knowledge-focused Recruiting nowThis study aims to find biological markers in the blood and tumor that can predict how patients with advanced skin cancer (cutaneous squamous cell carcinoma) will respond to the immunotherapy drug cemiplimab. Researchers will enroll about 30 patients starting this treatment and u…
Matched conditions: CUTANEOUS SQUAMOUS CELL CARCINOMA (CSCC)
Sponsor: Instituto de Investigación Biomédica de Salamanca • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:10 UTC
-
Blood test could predict skin cancer outcomes
Knowledge-focused Recruiting nowThis study aims to find blood markers that might help predict how skin cancer will progress and respond to treatment. Researchers will collect blood samples from 20 adults with melanoma or other skin cancers who are undergoing regular treatment. The goal is to see if certain subs…
Matched conditions: CUTANEOUS SQUAMOUS CELL CARCINOMA (CSCC)
Sponsor: University of Wisconsin, Madison • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:34 UTC
-
Flu shot fights cancer? early trial tests direct tumor injection
Knowledge-focused Recruiting nowThis early-phase study is testing if injecting a standard flu vaccine directly into a type of skin cancer tumor can change the immune cells inside it. Researchers will study the tumor tissue from 25 participants after this injection and their standard surgery to see if the vaccin…
Matched conditions: CUTANEOUS SQUAMOUS CELL CARCINOMA (CSCC)
Phase: EARLY_PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:38 UTC